Mordechai Pras

Q: What Schools Are Affiliated With Mordechai Pras

Mordechai Pras is affiliated with the following schools: Tel Aviv University, New York University

Mordechai Pras's AcademicInfluence.com Rankings

Mordechai Pras

Philosophy

#8162

World Rank

#11489

Historical Rank

Logic

#5193

World Rank

#6572

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Mordechai Pras Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mordechai Pras's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Criteria for the diagnosis of familial Mediterranean fever. (1997) (1424)
Familial Mediterranean fever. A survey of 470 cases and review of the literature. (1967) (1277)
Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. (1986) (606)
The characterization of soluble amyloid prepared in water. (1968) (590)
A controlled trial of colchicine in preventing attacks of familial mediterranean fever. (1974) (371)
The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. (1972) (351)
Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. (1999) (306)
Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT (1999) (303)
Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. (1992) (266)
Dominant inheritance in two families with familial Mediterranean fever (FMF). (1995) (258)
Long-term colchicine treatment in children with familial Mediterranean fever. (1991) (223)
IMMUNOLOGIC STUDIES OF THE MAJOR NONIMMUNOGLOBULIN PROTEIN OF AMYLOID (1973) (203)
MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. (1999) (196)
Raft lipids as common components of human extracellular amyloid fibrils. (2005) (193)
Clinical disease among patients heterozygous for familial Mediterranean fever. (2009) (182)
The changing face of familial Mediterranean fever. (1996) (174)
Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene. (1998) (160)
Low‐Molecular‐Weight Heparin During Pregnancy and Delivery: Preliminary Experience With 41 Pregnancies (1996) (155)
Protracted febrile myalgia in patients with familial Mediterranean fever. (1994) (141)
Activation of the cytokine network in familial Mediterranean fever. (1999) (139)
Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. (2000) (138)
Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome. (1994) (136)
Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. (2001) (131)
Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. (1989) (127)
Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF). (1997) (123)
Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene (2005) (121)
Behçet's disease in Familial Mediterranean fever: characterization of the association between the two diseases. (2000) (116)
Primary structure of an amyloid prealbumin variant in familial polyneuropathy of Jewish origin. (1983) (116)
Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups. (1982) (113)
Localization of a gene causing cystinuria to chromosome 2p (1994) (111)
PHYSICAL, CHEMICAL, AND ULTRASTRUCTURAL STUDIES OF WATER-SOLUBLE HUMAN AMYLOID FIBRILS : COMPARATIVE ANALYSES OF NINE AMYLOID PREPARATIONS (1969) (111)
Clinical and diagnostic value of genetic testing in 216 Israeli children with Familial Mediterranean fever. (2003) (110)
Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis. (1986) (106)
Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. (1998) (101)
Seronegative spondyloarthropathy in familial Mediterranean fever. (1997) (94)
Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever. (1992) (93)
Prevalence of ischemic heart disease in patients with familial Mediterranean fever. (2001) (91)
Erysipelas-like erythema of familial Mediterranean fever: clinicopathologic correlation. (2000) (91)
Protracted arthritis in familial Mediterranean fever. (1977) (87)
A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease (FMF-BD) (2001) (85)
Mutations in the SLC3A1 transporter gene in cystinuria. (1995) (79)
[Familial Mediterranean fever]. (1960) (74)
Molecular analysis of cystinuria in Libyan Jews: exclusion of the SLC3A1 gene and mapping of a new locus on 19q. (1997) (73)
Late-onset familial Mediterranean fever (FMF): a subset with distinct clinical, demographic, and molecular genetic characteristics. (1999) (71)
The Effect of Cyclophosphamide Pulses on Fertility in Patients With Lupus Nephritis (1992) (69)
Tumor necrosis factor in familial Mediterranean fever. (1991) (65)
A variant of prealbumin from amyloid fibrils in familial polyneuropathy of Jewish origin (1981) (61)
Degradation and deposition of amyloid AA fibrils are tissue specific. (1987) (61)
Colchicine in the treatment of AA and AL amyloidosis. (1993) (59)
The amino acid sequence of duck amyloid A (AA) protein. (1977) (59)
Apolipoprotein E Carboxyl-terminal Fragments Are Complexed to Amyloids A and L (1995) (59)
Treatment of resistant rheumatoid arthritis with minocycline: an open study. (1992) (57)
Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. (2003) (55)
Quality of life of patients with familial Mediterranean fever. (1997) (55)
Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine. (2003) (54)
Benefits and Risks of Minocycline in Rheumatoid Arthritis (2000) (52)
Pulmonary associations in familial Mediterranean fever. (1999) (52)
Letter: Colchicine in familial Mediterranean fever. (1976) (51)
Biochemical subtyping of amyloid in formalin-fixed tissue samples confirms and supplements immunohistologic data. (2004) (49)
Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease. (1999) (48)
Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: two diseases with distinct clinical, serologic, and genetic features. (1997) (47)
Thoracic and lung involvement in familial Mediterranean fever (FMF). (2002) (46)
A high-resolution genetic map of the familial Mediterranean fever candidate region allows identification of haplotype-sharing among ethnic groups. (1997) (45)
Protracted febrile myalgia of familial Mediterranean fever. Mutation analysis and clinical correlations. (2000) (45)
Circulating hydroxy fatty acids in familial Mediterranean fever. (1985) (44)
IMMUNOLOGIC STUDIES OF WATER-SOLUBLE HUMAN AMYLOID FIBRILS (1969) (43)
The primary structure of human tissue amyloid P component from a patient with primary idiopathic amyloidosis. (1985) (43)
Serum amyloid A protein in familial Mediterranean fever. (1985) (43)
THE SIGNIFICANCE OF MUCOPOLYSACCHARIDES IN AMYLOID (1971) (41)
Serum and synovial fluid levels of serum amyloid A protein and C-reactive protein in inflammatory and noninflammatory arthritis. (1988) (40)
Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity (2005) (39)
AA protein in a case of "primary" or "idiopathic" amyloidosis. (1980) (39)
Characterization of High Molecular Weight Amyloid A Proteins (1991) (39)
Amyloidosis associated with renal cell carcinoma of the AA type. (1982) (39)
Isolation of a non-collagenous reticulin component and its primary characterization. (1973) (38)
The partial amino acid sequence of the major low molecular weight component of two human amyloid fibrils (1972) (36)
Ground substance proteinpolysaccharides and the precipitation of calcium phosphate. (1968) (35)
Micropurification techniques in the analysis of amyloid proteins (2003) (34)
Functionally reversible hepatic arteriovenous fistulas during pregnancy in patients with hereditary hemorrhagic telangiectasia. (1988) (34)
Polyarteritis nodosa and familial Mediterranean fever. (1987) (34)
Total hip replacement in familial Mediterranean fever. (1993) (34)
The acid-soluble fraction of amyloid--a fibril forming protein. (1972) (32)
PHYSICAL, CHEMICAL, AND ULTRASTRUCTURAL STUDIES OF WATER-SOLUBLE HUMAN AMYLOID FIBRILS (1969) (32)
Demonstration of AA-protein in formalin-fixed, paraffin-embedded tissues. (1982) (32)
The Effect of Pregnancy on Renal Function in Amyloidosis of Familial Mediterranean Fever (1992) (31)
Binding of human serum amyloid P component (hSAP) to human neutrophils. (1994) (31)
Abdominal fat tissue aspirate in amyloidosis of familial Mediterranean fever. (1988) (30)
Recent advances in familial Mediterranean fever. (1984) (29)
Arthritis induced by filipin in rabbits. (1967) (28)
Serum amyloid A (SAA) in viral infection: rubella, measles and subacute sclerosing panencephalitis (SSPE). (1982) (28)
The molecular basis of reactive amyloidosis. (1995) (28)
Isolation and Characterization of Amyloid Proteins Using Milligram Amounts of Amyloid - Containing Tissue (1993) (27)
Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis (2005) (27)
Serum amyloid A levels in patients with infections due to cytomegalovirus, varicella-zoster virus, and herpes simplex virus. (1982) (26)
Amyloidotic polyneuropathy in a Jewish family. Evidence for the genetic heterogeneity of the lower limb familial amyloidotic neuropathies. (1985) (26)
Ethnic distribution and amyloidosis in familial Mediterranean fever (FMF). (1961) (26)
Twin studies in familial Mediterranean fever. (1992) (26)
Immunochemical characterization of amyloid in diagnostic biopsy tissues (1997) (25)
Antigenic properties of a non-collagenous reticulin component of normal connective tissue. (1974) (24)
Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246. (1996) (24)
Direct Evidence for SAA Deposition in Tissues During Murine Amyloidogenesis (1994) (23)
Studies of lysosomes. 8. The effect of polyene antibiotics on lysosomes. (1967) (23)
Inhibition of the second phase of amyloidogenesis in a mouse model by a single-dose colchicine regimen. (2001) (23)
Extremely active murine amyloid enhancing factor. (1996) (23)
An Ancillary Tool for the Diagnosis of Amyloid A Amyloidosis in a Variety of Domestic and Wild Animals (2005) (23)
Construction of a 1-Mb restriction-mapped cosmid contig containing the candidate region for the familial Mediterranean fever locus (MEFV) on chromosome 16p 13.3. (1997) (22)
Light chain amyloidosis of the urinary bladder. A site restricted deposition of an externally produced immunoglobulin. (2001) (21)
Expression and functions of very late antigen 1 in inflammatory joint diseases (2004) (21)
Preparative fractionation of amyloid proteins on a microgram scale by high-performance liquid chromatography and polyacrylamide gel electrophoresis. (1987) (21)
Nocardia asteroides infection complicating rheumatoid arthritis. (1991) (21)
Case reports. Severe enterocolitis complicating chrysotherapy. (1973) (21)
PRIMARY PERI-RETICULAR ('TYPICAL') AMYLOIDOSIS IN ISRAEL: ITS RELATION TO FAMILIAL MEDITERRANEAN FEVER. (1963) (20)
Imaging of experimental amyloidosis with 131I-labeled serum amyloid P component. (1987) (20)
An adult form of juvenile rheumatoid arthritis. (1980) (20)
Fibromyalgia in familial Mediterranean fever. (1994) (20)
Thromboembolism in a patient with transient eosinophilia and thrombocytopenia. (2000) (19)
Familial Mediterranean fever in the colchicine era: the fate of one family. (1993) (18)
Crush and smear technique for rapid detection and semiquantitation of amyloid deposition. (1991) (18)
The immune system in familial Mediterranean fever. (1983) (18)
Localized eosinophilic fasciitis in a child. (1980) (17)
Biochemical and clinical studies in Libyan Jewish cystinuria patients and their relatives. (1998) (17)
The kidney in familial Mediterranean fever. (1993) (17)
Determination of amyloid type by ELISA using milligram amounts of tissue. (1994) (17)
Characterization of amyloid deposits and P component from a patient with factor X deficiency reveals proteins derived from a lambda VI light chain. (1983) (16)
Antibodies against acetylcholinesterase and low levels of cholinesterases in a patient with an atypical neuromuscular disorder. (1988) (16)
Nodular cutaneous amyloidosis. (1991) (16)
The prevention of amyloidosis in familial Mediterranean fever with colchicine. (1985) (15)
Binding of human serum amyloid A (hSAA) and its high-density lipoprotein3 complex (hSAA-HDL3) to human neutrophils. Possible implication to the function of a protein of an unknown physiological role. (2009) (15)
Amyloidosis of Familial Mediterranean Fever and the MEFV Gene (2000) (15)
Increased prevalence of joint manifestations in patients with recurrent aphthous stomatitis (RAS) (1996) (15)
Intestinal Strangulation Complicating Familial Mediterranean Fever* (1966) (15)
Familial Mediterranean fever: new aspects and prospects at the end of the millenium. (1999) (15)
Intractable RA--treatment with combined methotrexate, azathioprine and hydroxychloroquine. (1989) (14)
The gene causing familial mediterranean fever maps to the short arm of chromosome 16 in Druze and Moslem Arab families (1994) (14)
Determination of autoantibodies in patients with familial Mediterranean fever and their first degree relatives. (1991) (13)
Isolation and purification of two major serum amyloid A isotypes SAA1 and SAA2 from the acute phase plasma of mice. (1997) (12)
Expansion of a unique subpopulation of cytotoxic T cells that express a C alpha V delta 1 T-cell receptor gene in a patient with severe persistent neutropenia. (1992) (12)
Isolation and purification of amyloid protein A by sodium dodecyl sulphate polyacrylamide gel electrophoresis and reversed-phase high-performance liquid chromatography. (1992) (12)
Laparoscopic splenectomy for torsion of wandering spleen associated with celiac axis occlusion (2002) (12)
Apolipoprotein E genotypes in AA and AL amyloidoses (1995) (12)
Idiopathic AL-kiv amyloidosis presenting as giant hepatomegaly. (1982) (12)
Aurothioglucose overdosage in five patients with rheumatoid arthritis (1987) (11)
Cyclosporine toxicity in amyloidotic patients. (1987) (11)
Identification of a New Prealbumin (Transthyretin) Variant in Cardiac Tissue: Immunologic and Biochemical Similarity to One Form of Familial Amyloidotic Polyneuropathy (1989) (11)
Vasculitis in familial Mediterranean fever (1996) (11)
Biochemical assay for amyloid beta deposits to distinguish Alzheimer's disease from other dementias. (1999) (11)
D-Penicillamine in Rheumatoid Arthritis (1975) (11)
Neutrophil Adhesion Molecule Expression in Familial Mediterranean Fever: Discordance between the Intravascular Regulation of β2 Integrin and L-Selectin Expression in Acute Attack (2004) (11)
Amyloid goiter: Report of the clinical, histological and biochemical features of five cases (1995) (10)
Pregnancy and amyloidogenesis: I. Offspring of amyloidotic mice are not predisposed to develop amyloidosis. (1999) (10)
Amyloid arthropathy: characterization of the amyloid protein. (1985) (10)
METACHROMATIC PROPERTIES OF AMYLOID IN SOLUTION (1969) (10)
Detection of serum amyloid A-derived proteins in formalin-fixed paraffin-embedded tissues: reliability of the method and expansion of its spectrum. (1997) (9)
Outcome of pregnancy in three patients with primary antiphospholipid syndrome after stroke. (1998) (9)
Cyclosporine and familial Mediterranean fever amyloidosis. (1986) (9)
Serum amyloid-A protein concentrations in sarcoidosis. (1989) (9)
[Familial Mediterranean fever]. (1991) (9)
Cryofibrinogen in familial Mediterranean fever. (1974) (9)
Separation of proteins by consecutive sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and reversed phase high performance liquid chromatography. (1991) (8)
Removal of sodium dodecyl sulphate from proteins by gel permeation chromatography. (1987) (8)
Abdominal CT findings in nephropathic amyloidosis of familial Mediterranean fever (2001) (8)
Serum amyloid A complexed with extracellular matrix induces the secretion of tumor necrosis factor-α by human T-lymphocytes (1998) (8)
Pregnancy and amyloidosis: II. Suppression of amyloidogenesis during pregnancy. (2000) (8)
Removal of sodium dodecyl sulphate from proteins isolated by sodium dodecyl sulphate polyacrylamide gel electrophoresis. (1990) (7)
[Amyloidosis and familial Mediterranean fever]. (1986) (7)
Absence of interferon activity during acute attacks of familial Mediterranean fever. (1980) (7)
HLA antigen in familial mediterranean fever. (2008) (7)
Degradation of amyloid A and serum amyloid A by red blood cell haemolysate in patients with familial mediterranean fever (1984) (7)
Familial Mediterranean fever: no association of HLA with amyloidosis or colchicine treatment response. (1985) (7)
Long-term effects of amyloid enhancing factor: clinical and experimental implications. (1998) (7)
A possible favorable effect of colchicine in IgA nephropathy in a carrier of a MEFV mutation. (2004) (6)
Studies on the amyloid A protein (AA protein) and a related serum component-purification-partial characterization and tissue origin and distribution in different types of amyloidosis. (1975) (6)
Chronic colchicine treatment does not impair glucose tolerance in familial Mediterranean fever patients (1997) (6)
Familial Mediterranean fever: Penetrance of the p.[Met694Val];[Glu148Gln] and p.[Met694Val];[=] genotypes (2020) (6)
Systemic amyloidosis secondary to chronic leg ulcers. (1992) (6)
Separation of Amyloid Proteins by Size-Exclusion Chromatography in Aqueous Organic Mobile Phase (1992) (6)
TUMOUR NECROSIS FACTOR IN FAMILIAL MEDITERRANEAN FEVER (1989) (6)
Suppression of amyloidogenesis in a mouse model by corticosteroid intervention. (2007) (5)
Dermatomyositis in a patient with malignant melanoma. (1994) (5)
Biochemical Micro-Techniques in the Diagnosis and Classification of Amyloidosis (2006) (5)
Combined use of micro-preparative gel electrophoresis and reversed-phase high-performance liquid chromatography for purification of amyloid beta peptides deposited in brains of Alzheimer's disease patients. (2002) (5)
Minocycline in rheumatoid arthritis. (1996) (5)
Genetic Heterogeneity of Familial Amyloid Polyneuropathies of Jewish Type (1986) (5)
Quantification of tissue amyloid content in AA amyloidosis by inhibition ELISA (1995) (4)
The Effect of SAA-Derived Fragment — SAA2–82 — On Platelet Aggregation (1991) (4)
Frequency of secondary amyloidosis in hospital patients in Malawi. (1966) (4)
Low Sensitivity of Ultrasonography for the Early Diagnosis of Amebic Liver Abscess (2004) (4)
Bound amino acids in uremic sera: search for peptidic middle molecules by preparative polyacrylamide gel electrophoresis and high performance liquid chromatography. (1989) (4)
Increased propensity for amyloidogenesis in male mice. (2004) (4)
Amyloid in urinary sediments as a diagnostic technique. (1979) (4)
Familial Mediterranean fever in two Bedouin families: mutation analysis and disease severity. (2000) (4)
Attempts at suppression of amyloidogenesis in a mouse model by a variety of anti-inflammatory agents. (2012) (4)
[Immunological studies by the agar gel diffusion technic in familial Mediterranean fever (FMF). Preliminary report]. (1961) (3)
Extremely high dose pravastatin may suppress amyloidogenesis in a mouse model (2002) (3)
The origin of the FMF gene. (1995) (3)
Primary Characterization of a Non-Collagenous Reticulin Component (1973) (3)
Effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever. (1993) (3)
Two New DNA-Based Tests for Mutations Causing Familial Amyloidotic Polyneuropathy (1988) (3)
Elevated anti-serum amyloid P component (SAP) antibodies in SLE patients (2003) (3)
The hemolytic effect of various sulfonamides on subjects with a deficiency of glucose-6-phosphate dehydrogenase of erythrocytes. (1959) (3)
Severe aortic regurgitation: A rare presentation of giant cell arteritis (1986) (3)
[Continuous colchicine therapy in familial mediterranean fever]. (1976) (3)
Exclusion of linkage between familial Mediterranean fever and the human serum amyloid A (SAA) gene cluster (1991) (3)
A Simple Procedure of Immunochemical Detection of Amyloid β Proteins using Milligram Amounts of Brain Tissues of Patients with Alzheimer’s Disease (1998) (2)
Azathioprine enhances experimental amyloidosis and attenuates colchicine protection against organ deposition of amyloid. (1991) (2)
Evidence for linkage of the gene causing familial Mediterranean fever to chromosome 17q in non-Ashkenazi Jewish families: second locus or type I error? (1993) (2)
[Reactive amyloidosis: advances in understanding its basic mechanisms]. (1996) (2)
Hydrocortisone Suppresses the Second Phase of Amyloidogenesis in a Mouse Model (2004) (2)
Separation of peptides from sodium dodecyl sulphate by high-performance liquid chromatography. (1989) (2)
Systemic Amyloidosis: Tissue Specific Variability in the Primary Structure of Amyloid Proteins (1988) (2)
The Hereditary Amyloidoses (1986) (1)
Normal renin-aldosterone-insulin and potassium interrelationship in FMF patients and amyloid nephropathy. (1992) (1)
Specific antiserum to rheumatoid arthritis amyloid and its cross reactivity with various amyloid preparation. (1973) (1)
[Pulmonary disease induced by methotrexate]. (1990) (1)
[Effect of colchicine on the amyloidosis of familial Mediterranean fever]. (1985) (1)
Contents Vol. 60, 1999 (1999) (1)
Anti-serum amyloid component P (SAP) antibodies in SLE patients correlate with disease activity Category-Extended report (2005) (1)
[Familial Mediterranean fever]. (1960) (1)
Antiplatelet Aggregation Activity of Serum Amyloid a (SAA) Related Peptides (1991) (1)
INCREASED PROPENSITY FORAMYLOIDOGENESIS IN MALE MICE (2004) (1)
Atherosclerosis and Familial Mediterranean Fever (2001) (1)
The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients (1996) (1)
Enzymatic processing of serum proteins: A route to peptides associated with host defense (1993) (1)
Analysis of the Interactions Between Amyloid Fibrils and Lipid Components (2004) (1)
Cloning of the familial Mediterranean fever gene: expectations for learning about the pathogenesis of amyloid A amyloidosis. (1998) (1)
Incidence of ambulatory pulmonary embolism. (1987) (1)
[Periodic arthralgia: teratogenicity of colchicine and its influence on pregnancy and sterility (author's transl)]. (1981) (1)
[Ancient mutations in the Sons of Shem cause familial Mediterranean fever]. (1997) (1)
The Impact of Colchicine on the Amyloidosis of Familial Mediterranean Fever (FMF) (1986) (1)
Molecular Analysis ofCystinuria inLibyan Jews: Exclusion ofthe SLC3A1GeneandMapping ofa New Locuson 19q (1997) (0)
Effect of Continuous Colchicine Treatment in Familial Mediterranean Fever (F.M.F) (1991) (0)
Serumamyloid A (SAA)variations inpatients with cancer: correlation withdisease activity, stage, primary site, andprognosis (1986) (0)
Proceedings of the Seventh International Conference of the International Society of Geographical Pathology (1961) (0)
Serum Amyloid A (SAA)-Related Peptide Isolated from Synovial Fluid Modulates Superoxide Production by Human Neutrophils. (1991) (0)
The Effect of a Variety of Anti-Inflammatory Drugs on Murine Amyloidogenesis (2007) (0)
Serum Amyloid A Complexed with Extracellular Matrix Induces the Secretion of Tumor Necrosis Factor-α by human T-lymphocytes (2004) (0)
Role of laparascopy prior to second‐look laparatomies in patients operated upon for ovarian cancer (1996) (0)
Clinical and radiological findings in gold reaction enteritis. Long-term follow-up. (1978) (0)
Proteolysis of acute phase proteins: Implication to the anti-inflammatory response (1992) (0)
Potential of cervical electrosurgical excision procedure for diagnosis and treatment of cervical intraepithelial neoplasia (1996) (0)
Glomerular Diseases in Special Populations (1984) (0)
Isolation and Primary Characterization of a Non-collagenous Reticulin Component (1975) (0)
Mutations intheSLC3AITransporter GeneinCystinuria (1995) (0)
[Familial Mediterranean fever: from the clinical syndrome through the localization of the gene to the exploration of the biochemical anomaly]. (1993) (0)
Serum CA-125 in familial mediterranean fever peritonitis (1991) (0)
V.1 THE HEREDITARY AMYLOIDOSES (1986) (0)
[Activity scores in systemic lupus erythematosus]. (1991) (0)
Lower Propensity for Amyloidogenesis in Female Mice (2004) (0)
Subject Index, Vol. 60, 1992 (1992) (0)
Mediterranean Symposium of rheumatology (1985) (0)
Genet ics Analysis of the Three Most Common MEFV Mutations in 412 Patients with Familial Mediterranean Fever (2003) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mordechai Pras?

Mordechai Pras is affiliated with the following schools:

Mordechai Pras's Academic­Influence.com Rankings

Why Is Mordechai Pras Influential?

Mordechai Pras's Published Works

Published Works

What Schools Are Affiliated With Mordechai Pras?

Mordechai Pras's AcademicInfluence.com Rankings